Literature DB >> 15561048

Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy.

Subrato J Deb1, Hartzell V Schaff, Joseph A Dearani, Rick A Nishimura, Steve R Ommen.   

Abstract

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterized by ventricular hypertrophy that occurs in the absence of predisposing cardiovascular stimuli; approximately one quarter of patients with HCM will have left ventricular (LV) outflow tract obstruction. Transaortic septal myectomy relieves outflow gradients and improves symptoms, but the effect of operation on ventricular hypertrophy is not well defined.
METHODS: We reviewed 60 patients who underwent septal myectomy for obstructive HCM; all had complete two-dimensional and Doppler studies including calculation of LV mass and LV mass index before operation and after dismissal.
RESULTS: Before myectomy the mean LV outflow gradient was 67 +/- 44 mm Hg, and at dismissal the mean LV outflow gradient was 12 +/- 13 mm Hg (p < 0.004). We found a significant decrease in the LV mass and LV mass index that occurred early after operation and persisted beyond 2 years follow-up. The early decrease in LV mass was greatest in patients younger than 50 years, but patients of all ages benefited from extended septal myectomy with decrease in LV hypertrophy.
CONCLUSIONS: Transaortic septal myectomy results in significant decreases in LV mass and LV mass index. This favorable remodeling occurs early after operation and persists beyond 2 years. Whether the regression of LV mass continues to decrease or stabilize over time is unclear.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561048     DOI: 10.1016/j.athoracsur.2004.05.063

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  A new technique to avoid the intraoperative complications of septal myectomy in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Oguz Omay; Emre Ozker; Serdar Celebi; Kaya Suzer; Ilhan Ozgol
Journal:  Heart Vessels       Date:  2009-01-23       Impact factor: 2.037

Review 2.  Contemporary treatment of hypertrophic cardiomyopathy.

Authors:  Ali J Marian
Journal:  Tex Heart Inst J       Date:  2009

3.  Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy.

Authors:  Marco Canepa; Lars L Sorensen; Iraklis Pozios; Veronica L Dimaano; Hong-Chang Luo; Aurelio C Pinheiro; James B Strait; Claudio Brunelli; M Roselle Abraham; Luigi Ferrucci; Theodore P Abraham
Journal:  Am J Cardiol       Date:  2013-10-15       Impact factor: 2.778

Review 4.  The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.

Authors:  Iacopo Olivotto; Francesca Girolami; Stefano Nistri; Alessandra Rossi; Luigi Rega; Francesca Garbini; Camilla Grifoni; Franco Cecchi; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2009-10-27       Impact factor: 4.132

5.  Peak systolic longitudinal strain of the lateral left ventricular wall improves after septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography.

Authors:  Lothar Faber; Christian Prinz; Dirk Welge; Detlef Hering; Thomas Butz; Olaf Oldenburg; Nicola Bogunovic; Dieter Horstkotte
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-08       Impact factor: 2.357

6.  Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy.

Authors:  Stefan A J Timmer; Tjeerd Germans; Marco J W Götte; Iris K Rüssel; Pieter A Dijkmans; Mark Lubberink; Jurrien M ten Berg; Folkert J ten Cate; Adriaan A Lammertsma; Paul Knaapen; Albert C van Rossum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

Review 7.  Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Angelos G Rigopoulos; Hubert Seggewiss
Journal:  Curr Cardiol Rev       Date:  2016

8.  Influence of operator volume on early outcomes of septal myectomy for isolated hypertrophic obstructive cardiomyopathy.

Authors:  Haojie Li; Long Deng; Hanning Liu; Sipeng Chen; Chenfei Rao; Yajie Tang; Shuiyun Wang; Sheng Liu; Hansong Sun; Yunhu Song
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

9.  Impact of septal myectomy on diastolic function in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Qiulan Yang; Hao Cui; Changsheng Zhu; Haibo Hu; Jianhua Lv; Yao Liu; Yang Zhang; Hartzell V Schaff; Shuiyun Wang
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

10.  Left ventricular remodeling following septal myectomy in hypertrophic obstructive cardiomyopathy.

Authors:  Tsuyoshi Yamabe; Jonathan Ginns; Vijay Vedula; Jay S Leb; Yuichi J Shimada; Shepard D Weiner; Hiroo Takayama
Journal:  JTCVS Open       Date:  2022-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.